FDA Approves Tirzepatide for Obstructive Sleep Apnea

from TheBrief.Health · host TheBrief.Health

Tirzepatide significantly reduced obstructive sleep apnea severity and body weight in adults with obesity, supporting FDA-approved treatment alongside lifestyle changes and PAP therapy.

Episode metadata supplied by the publisher feed · Published Aug 14, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

FDA Approves Tirzepatide for Obstructive Sleep Apnea

0:00 1:51

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on August 14, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!